Geneva, April 27 -- International Clinical Trials Registry received information related to the study (NCT07537517) titled 'Evaluation of the BMPR2-Activin Signaling Pathway in Group II Pulmonary Hypertension' on April 9.

Study Type: Observational [Patient Registry]

Primary Sponsor: Hospital General Universitario Gregorio Marañon

Condition: Pulmonary Hypertension Due to Left Heart Disease Pulmonary Hypertension (PH) Heart Failure

Recruitment Status: Recruiting

Date of First Enrollment: November 1, 2025

Target Sample Size: 150

Countries of Recruitment: Spain

To know more, visit https://clinicaltrials.gov/study/NCT07537517

Disclaimer: Curated by HT Syndication....